⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CAPR News
Capricor Therapeutics Inc
Exosome Therapy Market Size and Industry Dynamics 2026-2035 - Standardization Challenges Loom Over Booming $58 Billion Exosome Therapy Industry
globenewswire.com
CRBP
CAPR
AEMD
COYA
EVOX
Capricor Therapeutics Announces Late-Breaking Presentation of HOPE-3 Phase 3 Results at the American Academy of Neurology 2026 Annual Meeting
globenewswire.com
CAPR
Capriotti's Scores Big with Las Vegas Lights FC as Official Sandwich Partner
prnewswire.com
CAPR
Form 8-K
sec.gov
CAPR
Capricor Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
globenewswire.com
CAPR
Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Atkore Inc. (ATKR), Axsome Therapeutics, Inc. (AXSM), Capricor Therapeutics, Inc. (CAPR), and CTO Realty Growth, Inc. (CTO)
globenewswire.com
ATKR
AXSM
CAPR
CTO
Capricor Therapeutics Announces Late-Breaking HOPE-3 Data at the 2026 MDA Conference Demonstrating Significant Functional Benefits of Deramiocel for Duchenne Muscular Dystrophy
globenewswire.com
CAPR
Form 8-K
sec.gov
CAPR
Capricor Therapeutics Announces Establishment of New PDUFA Date for Deramiocel BLA
globenewswire.com
CAPR
Capricor Therapeutics Announces Establishment of New PDUFA Date for Deramiocel BLA
globenewswire.com
CAPR